Introduction
============

Sepsis, which can progress to severe sepsis and septic shock, is becoming a major healthcare problem and affects millions of people around the world each year \[[@B1]-[@B5]\]. The emergency department (ED) is a common location for the initial evaluation and management of septic patients. However, evaluation is complicated by the heterogeneity of clinical manifestations, sites of infection, comorbid conditions, and etiologic microorganisms \[[@B6]\]. Given the complexity of sepsis, biomarkers and mathematical models offer potential guidance once they have been carefully validated \[[@B7],[@B8]\].

The concept of the predisposition, infection, response, and organ dysfunction (PIRO) scoring system was recommended at the 2001 International Sepsis Definitions Conference to improve the traditional classification of sepsis \[[@B9]\]. The PIRO system is an ideal staging system that incorporates assessment of premorbid baseline susceptibility (predisposition), the specific disorder responsible for illness (infection), the response of the host to infection, and the resulting degree of organ dysfunction. The four components of the PIRO system cover multiple known independent factors that may influence the onset, development, and outcome of sepsis. The system was proposed not as a prognostic measure, but rather as a stratification tool to resolve the inherent heterogeneity of septic patients. The PIRO system was expected to be helpful for risk stratification and for enrollment criteria in clinical studies, and to differentiate patients who may benefit from certain types of therapeutic intervention.

The PIRO system is theoretically an ideal stratification tool, but it is difficult to translate into clinical practice. In 2008, the first clinical PIRO model was developed \[[@B10]\], followed by another three different PIRO systems over the next 5 years. The variables contained in these PIRO systems varied markedly, partly because of different enrollment populations. Three studies enrolled septic patients admitted to the ICU and another enrolled patients with suspected infection in the ED. The PIRO systems were based on ICU populations with ICU-specific variables, such as the location and length of stay prior to ICU admission, the reason for ICU admission, and the infective agents, so they were not very suitable for application in the ED \[[@B10]-[@B13]\]. The PIRO system devised by Howell and colleagues was developed in patients in the ED with suspected infection and was designed for bedside use at clinical presentation \[[@B12]\]. The variables of this PIRO system were easily obtained in the ED, so its applicability was superior to others. Since the original study mainly focused on the prognostic value of PIRO, the system's risk stratification ability needs further evaluation.

This study was designed to assess the predictive performance of the PIRO system for ICU admission, development of multiple organ dysfunction (MOD), and 28-day mortality in septic patients in the ED, and to compare this scoring system with the Acute Physiology and Chronic Health Evaluation (APACHE) II \[[@B14]\] and Mortality in Emergency Department Sepsis (MEDS) scores \[[@B7]\].

Materials and methods
=====================

Patients
--------

We conducted a prospective observational clinical study in the ED of Beijing Chao-Yang Hospital, a teaching hospital of Capital Medical University with approximately 250,000 ED visits per year. The study was approved by the Beijing Chao-Yang hospital ethics committee, and written informed consent was obtained from every patient.

The enrollment criteria were age ≥ 18 years and fulfillment of the sepsis criteria as defined by the International Sepsis Definitions Conference \[[@B9]\]. The exclusion criteria were as follows: age \< 18 years, terminal stage of disease (malignant cancer with metastases, AIDS, end-stage renal or hepatic disease, chronic heart failure), and refusal to participate in the study by patients or their relatives.

Data collection
---------------

Patients' basic information, including age, gender, comorbidities, telephone number, and medical record number, was recorded at the time of enrollment. Vital signs, laboratory results, and imaging results obtained on ED arrival were documented, together with diagnoses. The PIRO \[[@B12]\], APACHE II \[[@B14]\], and MEDS \[[@B7]\] scores were calculated using data obtained on ED arrival. The criteria for the four PIRO domains are presented in Table [1](#T1){ref-type="table"}.

###### 

Criteria of the PIRO system

  **Variable**                      **0**   **1**                **2**             **3**   **4**
  --------------------------------- ------- -------------------- ----------------- ------- -------
  Predisposition                                                                            
    Age (years)                     \<65    65 to 80             \>80                       
    COPD                                    Yes                                             
    Liver disease                                                Yes                        
    Nursing home resident                                        Yes                        
    Malignancy                              Without metastases   With metastases            
  Infection                                                                                 
    Skin/soft tissue infection      Yes                                                     
    Any other infection                                          Yes                        
    Pneumonia                                                                              Yes
  Response                                                                                  
    Respiratory rate (bpm)                                                         \>20     
    Bands                                   \>5%                                            
    Heart rate (bpm)                                             \>120                      
  Organ dysfunction                                                                         
    SBP (mmHg)                      \>90                         70 to 90                  \<70
    BUN (mmol/l)                                                 \>7.1                      
    Respiratory failure/hypoxemia                                                  Yes      
    Lactate (mmol/l)                                                               \>4.0    
    Platelet count (×10^9^/l)                                    \<150                      

BUN, blood urea nitrogen; COPD, chronic obstructive pulmonary disease; PIRO, predisposition, infection, response, and organ dysfunction; SBP, systolic blood pressure.

Outcome variables
-----------------

All patients were followed up for 28 days through medical records or by telephone. Organ function was assessed at enrollment and was reassessed when deterioration occurred or on the third day of enrollment if the patient was relatively stable. ICU admission during follow-up, development of MOD within 3 days of enrollment, and 28-day mortality were considered as the outcome criteria. MOD was defined as fulfillment of two or more of the criteria of severe sepsis at any time within 3 days of enrollment, excluding organ dysfunction, which was induced by pre-existing disease.

Statistical analysis
--------------------

All data were analyzed by SPSS version 16.0 (SPSS Inc., Chicago, IL, USA). Normally distributed data were expressed as the mean ± standard deviation and were compared using the independent-samples *t* test. Data with skewed distribution were expressed as the median and quartiles and were analyzed by the Mann--Whitney *U* test. The chi-square test was used for the comparison of frequencies. Logistic regression analysis was used to determine independent predictors of outcomes. Receiver operating characteristic (ROC) curves were constructed and the area under the ROC curves (AUC) was determined to assess predictive value. All statistical tests were two-tailed, and *P* \< 0.05 was considered statistically significant.

Results
=======

Characteristics of the study cohort
-----------------------------------

Eight hundred and thirty-seven consecutive septic patients were screened from November 2011 to October 2012. We excluded 153 patients with non-infectious disease and four patients with incomplete data, and thus included 680 septic patients in the study. The characteristics of the study cohort are presented in Table [2](#T2){ref-type="table"}.

###### 

Characteristics of the study cohort

  -------------------------------------------------- ---------------
  Number of patients                                 680
  Male (%)                                           61.2
  Age (years)                                        73 (60 to 79)
  Infection site                                      
    Pneumonia (*n*)                                  467
    Intra-abdominal infection (*n*)                  170
    Pyelonephritis                                   21
    Central nervous system infection (*n*)           18
    Other infections (*n*)                           4
  APACHE II score                                    17.0 ± 7.7
  MEDS score                                         11 (8 to 16)
  PIRO score                                         11 (9 to 14)
  28-day mortality (%)                               26.2
  ICU admission (%)                                  21.8
  Incidence of MOD within 3 days of enrollment (%)   34.4
  -------------------------------------------------- ---------------

APACHE, Acute Physiology and Chronic Health Evaluation; MEDS, Mortality in Emergency Department Sepsis; MOD, multiple organ dysfunction; PIRO, predisposition, infection, response, and organ dysfunction.

The mean age was much higher in patients subsequently admitted to the ICU (76 (range, 67 to 78) years) versus those who were not (72 (59 to 79) years, *P* = 0.012), in patients who developed MOD (75 (66 to 81) years) versus those who did not (71 (51 to 78) years, *P* \< 0.001), and in patients who died within 28 days (74 (65 to 81) years) versus survivors (73 (59 to 79) years, *P* = 0.012). The percentage of males did not differ between patients with different outcomes.

Risk stratification and prognostic performance of the PIRO system
-----------------------------------------------------------------

The predictive ability of each of the four components of the PIRO system was analyzed separately. The results are presented in Table [3](#T3){ref-type="table"}. Predisposition, infection, response, and organ dysfunction were all independent predictors of ICU admission. Predisposition, infection, and organ dysfunction independently predicted MOD, but response did not. For 28-day mortality, predisposition, response, and organ dysfunction were the independent predictors, but infection was not. The ROC curves are shown in Figure [1](#F1){ref-type="fig"}, and the AUCs are presented in Table [4](#T4){ref-type="table"}. The predictive ability of organ dysfunction was the best among the four components. The AUCs of organ dysfunction in predicting ICU admission, MOD, and 28-day mortality were 0.888, 0.851, and 0.816, respectively. A negative correlation was found between response and MOD, as well as between response and 28-day mortality.

###### 

Predictive ability of the four components of the PIRO system

  **Outcome variable**   **Predictor**        ***B***   **SE**   **Wald**   ***P*value**   **OR**   **95% CI for OR**  
  ---------------------- ------------------- --------- -------- ---------- -------------- -------- ------------------- -------
  ICU admission          Predisposition        0.387    0.140     7.591        0.006       1.472          1.118         1.939
                         Infection             0.440    0.210     4.382        0.036       1.553          1.028         2.344
                         Response              0.364    0.093     15.351       0.000       1.439          1.200         1.727
                         Organ dysfunction     0.665    0.058    132.428       0.000       1.944          1.736         2.177
                         Constant             −7.743    1.031     56.440       0.000       0.000                           
  MOD                    Predisposition        0.409    0.110     13.872       0.000       1.506          1.214         1.867
                         Infection             0.378    0.166     5.228        0.022       1.460          1.056         2.020
                         Response             −0.125    0.073     2.907        0.088       0.883          0.764         1.019
                         Organ dysfunction     0.544    0.044    154.852       0.000       1.723          1.582         1.878
                         Constant             −4.272    0.727     34.553       0.000       0.014                           
  28-day mortality       Predisposition        0.225    0.112     4.060        0.044       1.253          1.006         1.560
                         Infection            −0.017    0.144     0.014        0.904       0.983          0.741         1.303
                         Response             −0.331    0.073     20.345       0.000       0.718          0.622         0.829
                         Organ dysfunction     0.410    0.037    125.453       0.000       1.507          1.403         1.620
                         Constant             −1.906    0.591     10.391       0.001       0.149                           

CI, confidence interval; MOD, multiple organ dysfunction; OR, odds ratio; PIRO, predisposition, infection, response, and organ dysfunction; SE, standard error.

![**Receiver operating characteristic curves of the PIRO, MEDS and APACHE II scores for predicting outcomes. (a)** ICU admission. **(b)** Development of multiple organ dysfunction. **(c)** Twenty-eight-day mortality. APACHE, Acute Physiology and Chronic Health Evaluation; MEDS, Mortality in Emergency Department Sepsis; PIRO, predisposition (P), infection (I), response (R), and organ dysfunction (O).](cc13832-1){#F1}

###### 

Areas under the receiver operating characteristic curves of predictors

  **Outcome variable**   **Predictor**    **AUC**   **SE**   ***P*value**   **95% CI for AUC**  
  ---------------------- --------------- --------- -------- -------------- -------------------- -------
  ICU admission          PIRO              0.889    0.017       0.000             0.855          0.923
  Predisposition         0.570             0.026    0.009       0.520             0.621         
  Infection              0.528             0.026    0.299       0.477             0.579         
  Response               0.606             0.028    0.000       0.551             0.660         
  Organ dysfunction      0.888             0.017    0.000       0.856             0.921         
  MEDS                   0.774\*\*         0.022    0.000       0.731             0.817         
  APACHE II              0.789\*\*         0.020    0.000       0.750             0.829         
  MOD                    PIRO              0.817    0.017       0.000             0.785          0.849
  Predisposition         0.594             0.022    0.000       0.550             0.638         
  Infection              0.536             0.023    0.127       0.491             0.580         
  Response               0.487             0.025    0.573       0.438             0.536         
  Organ dysfunction      0.851             0.015    0.000       0.821             0.881         
  MEDS                   0.758\*           0.019    0.000       0.721             0.796         
  APACHE II              0.764\*           0.019    0.000       0.727             0.801         
  28-day mortality       PIRO              0.744    0.022       0.000             0.701          0.786
  Predisposition         0.555             0.025    0.029       0.507             0.603         
  Infection              0.507             0.025    0.795       0.457             0.556         
  Response               0.427             0.027    0.004       0.374             0.481         
  Organ dysfunction      0.816             0.019    0.000       0.780             0.852         
  MEDS                   0.736             0.022    0.000       0.693             0.779         
  APACHE II              0.742             0.022    0.000       0.700             0.784         

APACHE, Acute Physiology and Chronic Health Evaluation; AUC, area under the receiver operating characteristic curve; CI, confidence interval; MEDS, Mortality in Emergency Department Sepsis; MOD, multiple organ dysfunction; PIRO, predisposition, infection, response, and organ dysfunction; SE, standard error. Compared with PIRO: \*\**P* \< 0.01; \**P* \< 0.05.

Comparison of severity systems in patients with different outcomes
------------------------------------------------------------------

The average APACHE II, MEDS, and PIRO scores were significantly different between patients who did and did not meet the outcome criteria (*P* \< 0.001). The results are shown in Figure [2](#F2){ref-type="fig"}. As shown in Table [5](#T5){ref-type="table"}, both PIRO and APACHE II scores independently predicted ICU admission and MOD, but MEDS scores did not. All three scores were independent predictors of 28-day mortality and had similar AUC values.

![**Mean scores of severity systems between patients who did and did not meet the outcome criteria. (a)** Acute Physiology and Chronic Health Evaluation (APACHE) II score. **(b)** Mortality in Emergency Department Sepsis (MEDS) score. **(c)** Predisposition, infection, response, and organ dysfunction (PIRO) score. No, patients did not meet the outcome criteria; yes, patients met the outcome criteria. MOD, multiple organ dysfunction.](cc13832-2){#F2}

###### 

The independent predictors of outcomes

  **Outcome variable**   **Independent predictor**   ***B***   **SE**   **Wald**   ***P*value**   **OR**   **95% CI**   
  ---------------------- --------------------------- --------- -------- ---------- -------------- -------- ------------ -------
  ICU admission          PIRO                        0.564     0.061    84.853     0.000          1.758    1.559        1.982
                         MEDS                        −0.020    0.033    0.393      0.531          0.980    0.919        1.044
                         APACHE II                   0.045     0.022    4.233      0.040          1.046    1.002        1.092
                         Constant                    −9.292    0.744    155.773    0.000          0.000                  
  MOD                    PIRO                        0.295     0.041    53.053     0.000          1.343    1.241        1.454
                         MEDS                        0.042     0.026    2.747      0.097          1.043    0.992        1.097
                         APACHE II                   0.065     0.017    14.260     0.000          1.067    1.032        1.104
                         Constant                    −5.920    0.468    160.023    0.000          0.003                  
  28-day mortality       PIRO                        0.112     0.036    9.843      0.002          1.119    1.043        1.200
                         MEDS                        0.065     0.026    6.481      0.011          1.067    1.015        1.122
                         APACHE II                   0.075     0.017    20.207     0.000          1.078    1.043        1.114
                         Constant                    −4.628    .395     137.245    0.000          0.010                  

APACHE, Acute Physiology and Chronic Health Evaluation; CI, confidence interval; MEDS, Mortality in Emergency Department Sepsis; MOD, multiple organ dysfunction; OR, odds ratio; PIRO, predisposition, infection, response, and organ dysfunction; SE, standard error.

The ROC curves of APACHE II and MEDS scores are shown in Figure [1](#F1){ref-type="fig"}, and the AUCs are presented in Table [4](#T4){ref-type="table"}. The predictive ability of the PIRO score for ICU admission (AUC: 0.889) was much better than that of MEDS (AUC: 0.774) and APACHE II (AUC: 0.789) (*P* \< 0.01). The PIRO score was also better for predicting the development of MOD (AUC: 0.817) than MEDS (AUC: 0.758) and APACHE II (AUC: 0.764) scores (*P* \< 0.05). The AUC values of the three systems for 28-day mortality were similar.

Discussion
==========

It is important for the ED physician to identify high-risk septic patients who are likely to need aggressive resuscitation since significant physiologic changes from sepsis to severe sepsis and septic shock can occur rapidly in the early stages of sepsis. According to the 2012 International Guidelines for Management of Severe Sepsis and Septic Shock, resuscitation should be initiated in patients with sepsis-induced tissue hypoperfusion. In these guidelines, tissue hypoperfusion was defined as hypotension persisting after an initial fluid challenge, or a blood lactate concentration \> 4 mmol/l \[[@B15]\]. In fact, most patients with elevated lactate are in the late stages of sepsis, and they experience high mortality despite aggressive resuscitation. Development of a more useful tool for risk stratification and prognosis in septic patients is thus still essential. For this purpose, the PIRO concept was proposed. The four components of the PIRO system cover almost all of the factors that may influence the onset, development, and outcome of sepsis. However, translating the PIRO concept into clinical practice is very difficult because of the extremely complex pathophysiologic changes of sepsis. In 2008, Moreno and colleagues developed the first PIRO score \[[@B10]\]. During the next 5 years, three additional clinical studies focusing on the PIRO system were published \[[@B11]-[@B13]\]. The enrollment populations varied from patients with clinically suspected infections to patients with severe sepsis/septic shock admitted to the ICU. The illness severity of the enrollment cohort was significantly different in every study, and the in-hospital mortality ranged from 4.3% to 48.5%. The statistical methods of screening the variables also differed between studies. The PIRO systems developed in these studies were therefore very different. Additionally, these studies focused on the prognostic value of the PIRO system, and did not assess its performance in risk stratification.

The PIRO system assessed in the present investigation was developed from a study of 2,132 patients with suspected infections, and its prognostic value for in-hospital mortality was validated in an internal cohort (*n* = 4,618) and an external cohort (*n* = 1,004). In that initial study, the AUCs of the PIRO system in predicting in-hospital mortality were 0.90 in the derivation cohort, 0.86 in the internal validation cohort, and 0.83 in the external validation cohort \[[@B12]\]. This PIRO system incorporated 16 variables that were easily obtained in the ED and was superior to other PIRO systems for application in the ED. As the original PIRO enrollment cohort comprised patients with suspected infection who were relatively low risk (in-hospital mortality of 4.3%), its prognostic and risk stratification performance in septic patients required further assessment.

The present study assessed the predictive ability of the four components of the PIRO system separately and found that organ dysfunction was the best predictor of outcomes. The predictive value of each of the other three components was weaker. Some variables of the PIRO system (systolic blood pressure and lactate concentration) reflected established organ dysfunction and may partly account for the superior performance of organ dysfunction in predicting ICU admission and MOD. Another important result of our study is that response negatively correlated with MOD and 28-day mortality. As the criteria of response in the original PIRO were tachycardia, tachypnea, and elevated bands, patients who did not develop these symptoms were prone to adverse outcomes in the present study. Some septic patients manifest hypothermia and leucopenia instead of fever and leukocytosis, and their illness severity is more severe with poorer outcome \[[@B16]\]. This result suggests that adding hyporeactive variables in the PIRO system may be necessary.

Our study revealed that APACHE II, MEDS, and PIRO scores were much higher for patients admitted to the ICU than for those who were not. In binary logistic regression analysis, the independent predictors of ICU admission were the APACHE II and PIRO scores, but not the MEDS score. This may be because more organ dysfunction variables are used in the APACHE II and PIRO scores. Most patients were admitted to the ICU because they developed organ dysfunction that needed intensive therapy such as mechanical ventilation or continuous renal replacement therapy. The MEDS score incorporates fewer variables that reflect organ function, so its predictive ability for ICU admission is weaker. The superior predictive performance of the PIRO system for ICU admission may be helpful in establishing the disposition of septic patients in the ED.

MOD signals progressive deterioration and is associated with high short-term mortality \[[@B1],[@B3],[@B4]\]. In our study, both PIRO and APACHE II scores independently predicted the development of MOD within 3 days of ED arrival, but MEDS scores did not. The predictive value of the PIRO system was superior to that of APACHE II. The PIRO system incorporates both the high-risk factors of MOD, such as age, liver disease, malignancy, and residence in a nursing home, and variables reflecting established organ dysfunction, such as systolic blood pressure and lactate; therefore, its predictive value was found to be better. The APACHE II score contains organ dysfunction variables, such as mean artery pressure, creatinine, and oxygenation, but other variables did not reflect organ function, so its predictive value was weaker compared with the PIRO score.

The PIRO system was an independent predictor of 28-mortality in the present study. Its prognostic value was similar to that of MEDS and APACHE II scores. A previous study obtained analogous results \[[@B17]\]. The PIRO system may be able to replace MEDS and APACHE II scores as a prognostic scoring system after validation in larger cohorts in the future.

Limitations
-----------

Our study was limited by being a single-center study with a relatively small sample size. It is also important to recognize that the present study excluded 48 patients with terminal disease (malignant cancer with metastases, AIDS, end-stage renal or hepatic disease, chronic heart failure), which significantly influenced the short-term survival rate. Data for these patients were not recorded or analyzed. The absolute scores of MEDS, APACHE II, and PIRO may therefore be a little lower in the present study than in other studies that included terminal patients.

Conclusions
===========

The PIRO system is valuable in predicting 28-day mortality, ICU admission, and the development of MOD in septic patients in the ED. The PIRO score is superior to the MEDS and APACHE II scores for risk stratification, and its prognostic value is similar to MEDS and APACHE II scores. Organ dysfunction is the best predictor of ICU admission, MOD, and 28-day mortality among the four components of the PIRO system. The response component negatively correlated with MOD and 28-day mortality.

Key messages
============

• Organ dysfunction is the best predictor of ICU admission, MOD, and 28-day mortality among the four components of the PIRO system.

• The predictive ability of predisposition, infection, and response components is weaker than that of organ dysfunction.

• Response negatively correlates with MOD and 28-day mortality.

• The PIRO score is superior to the APACHE II and MEDS scores for predicting ICU admission and MOD.

• The prognostic performance of the PIRO system for 28-day mortality is similar to that of the MEDS and APACHE II scores.
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